They are naturally diverse in their phenotypeswhich range from light green to reddish pericarp, yellow, orange to red ariland unique but overlapping chemical profiles (Belgis et al
However, as results from the first two-year follow-up studies start to be released for these drugs, Jon Rees, CEO of MitoRx Therapeutics, believes that alternative treatments for obesity are still needed
The challenges and opportunities associated with reimbursement for obesity pharmacotherapy in the USA
If you have struggled with obesity for a long time, it is not recommended that you stop taking GLP-1 medication
Compounded semaglutide was available as an alternative for people unable to access semaglutide for their medical needs
Mounjaro is the latest GLP-1 weight loss injection available in the UK, and is the most effective